These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 14759357)

  • 1. Treatment of hypertension and prevention of ischemic stroke.
    Aronow WS; Frishman WH
    Curr Cardiol Rep; 2004 Mar; 6(2):124-9. PubMed ID: 14759357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trials on blood pressure-lowering and secondary stroke prevention.
    Chalmers J
    Am J Cardiol; 2003 May; 91(10A):3G-8G. PubMed ID: 12781902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP).
    Perry HM; Davis BR; Price TR; Applegate WB; Fields WS; Guralnik JM; Kuller L; Pressel S; Stamler J; Probstfield JL
    JAMA; 2000 Jul; 284(4):465-71. PubMed ID: 10904510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of blood pressure lowering on major vascular events among patients with isolated diastolic hypertension: the perindopril protection against recurrent stroke study (PROGRESS) trial.
    Arima H; Anderson C; Omae T; Woodward M; Hata J; Murakami Y; Macmahon S; Neal B; Chalmers J;
    Stroke; 2011 Aug; 42(8):2339-41. PubMed ID: 21700945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary prevention for stroke and transient ischaemic attacks: PROGRESS is about reducing blood pressure, not promoting drugs.
    Duerden M
    BMJ; 2004 Apr; 328(7444):896-7; author reply 897. PubMed ID: 15073082
    [No Abstract]   [Full Text] [Related]  

  • 6. Apparent Treatment-resistant Hypertension Among Individuals with History of Stroke or Transient Ischemic Attack.
    Howard VJ; Tanner RM; Anderson A; Irvin MR; Calhoun DA; Lackland DT; Oparil S; Muntner P
    Am J Med; 2015 Jul; 128(7):707-14.e2. PubMed ID: 25770032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term antihypertensive efficacy of perindopril according to clinical profile of 3,188 patients: A meta-analysis.
    Gasowski J; Wilkins A; Drzewoski J; Kłoś J; Gaciong Z; Kabat M; Grodzicki T
    Cardiol J; 2010; 17(3):259-66. PubMed ID: 20535716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive efficacy and safe use of once-daily sustained-release diltiazem in the elderly: a comparison with captopril. The Dilcacomp Study Group.
    Nicaise J; Neveux E; Blondin P
    J Int Med Res; 1995; 23(4):244-53. PubMed ID: 7589767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of angiotensin antagonism in stroke prevention in patients with hypertension: focus on losartan.
    Ferrario CM
    Curr Med Res Opin; 2004 Nov; 20(11):1797-804. PubMed ID: 15537480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment in the primary prevention of stroke--still not fully used option].
    Widimský J
    Cas Lek Cesk; 2004; 143(10):657-63. PubMed ID: 15584613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension, antihypertensive treatment and stroke prevention.
    Grassi G; Quarti F; Mancia G
    Neurol Sci; 2005 May; 26 Suppl 1():S22-3. PubMed ID: 15883684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind comparison of the antihypertensive efficacy and safety of once-daily losartan compared to twice-daily captopril in mild to moderate essential hypertension.
    Roca-Cusachs A; Oigman W; Lepe L; Cifkova R; Karpov YA; Harron DW
    Acta Cardiol; 1997; 52(6):495-506. PubMed ID: 9542575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulse pressure changes with six classes of antihypertensive agents in a randomized, controlled trial.
    Cushman WC; Materson BJ; Williams DW; Reda DJ
    Hypertension; 2001 Oct; 38(4):953-7. PubMed ID: 11641316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure control in the Hypertension in the Very Elderly Trial (HYVET).
    Bulpitt CJ; Beckett NS; Peters R; Leonetti G; Gergova V; Fagard R; Burch LA; Banya W; Fletcher AE
    J Hum Hypertens; 2012 Mar; 26(3):157-63. PubMed ID: 21390056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of treating hypertension in the elderly: a short commentary on current issues.
    Weber MA
    Am J Geriatr Cardiol; 2003; 12(1):14-8. PubMed ID: 12502910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug therapy for the secondary prevention of stroke in hypertensive patients: current issues and options.
    Lüders S
    Drugs; 2007; 67(7):955-63. PubMed ID: 17488141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of the Systolic Hypertension in China trial.
    Liu L; Wang JG; Celis H; Staessen JA
    Clin Exp Hypertens; 1999; 21(5-6):499-505. PubMed ID: 10423076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perindopril: an updated review of its use in hypertension.
    Hurst M; Jarvis B
    Drugs; 2001; 61(6):867-96. PubMed ID: 11398915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary prevention of stroke: old and new evidence.
    Mancia G; Grassi G
    Aging Clin Exp Res; 2002 Jun; 14(3):216-20. PubMed ID: 12387531
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk factors for stroke and type of stroke in persons with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.
    Davis BR; Vogt T; Frost PH; Burlando A; Cohen J; Wilson A; Brass LM; Frishman W; Price T; Stamler J
    Stroke; 1998 Jul; 29(7):1333-40. PubMed ID: 9660383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.